SUCLG1 and acute myeloid leukemia: In summary, these research findings provide novel insights into how FLT3 mutations contribute to the altered mitochondrial biogenesis characteristic of AML progression through their effect on SUCLG1 activation and subsequent decrease in POLRMT succinylation, pinpointing potential therapeutic targets.